{
    "clinical_study": {
        "@rank": "45", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Evaluate bronchoalveolar lavage fluid and serum obtained from pediatric\n      patients with storage disorders prior to allogeneic hematopoietic stem cell transplantation\n      (HSCT) for the presence of proinflammatory cytokines and for the production of nitric oxide\n      by alveolar macrophages to identify possible risk factors for pulmonary complications.\n\n      II.  Investigate the underlying mechanism for the development of significant pulmonary\n      complications in these patients during HSCT.\n\n      III.  Evaluate bronchoalveolar lavage fluid and serum obtained from these same patients at\n      the time a pulmonary complication develops post-HSCT, or at 60 days post-HSCT if there has\n      been no pulmonary complications."
        }, 
        "brief_title": "Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation", 
        "condition": [
            "I Cell Disease", 
            "Fucosidosis", 
            "Globoid Cell Leukodystrophy", 
            "Adrenoleukodystrophy", 
            "Mannosidosis", 
            "Niemann-Pick Disease", 
            "Pulmonary Complications", 
            "Mucopolysaccharidosis I", 
            "Mucopolysaccharidosis VI", 
            "Metachromatic Leukodystrophy", 
            "Gaucher's Disease", 
            "Wolman Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fucosidosis", 
                "Gaucher Disease", 
                "Mucolipidoses", 
                "Leukodystrophy, Globoid Cell", 
                "Leukodystrophy, Metachromatic", 
                "Mucopolysaccharidosis I", 
                "Alpha-Mannosidosis", 
                "Mannosidase Deficiency Diseases", 
                "Mucopolysaccharidoses", 
                "Mucopolysaccharidosis VI", 
                "Niemann-Pick Diseases", 
                "Niemann-Pick Disease, Type A", 
                "Niemann-Pick Disease, Type C", 
                "Wolman Disease", 
                "Adrenoleukodystrophy", 
                "Aphasia, Primary Progressive", 
                "Pick Disease of the Brain", 
                "Frontotemporal Dementia"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients undergo bronchoscopy with bronchoalveolar lavage (BAL) prior to allogeneic\n      hematopoietic stem cell transplantation (HSCT).  ELISA assays for cytokines are performed.\n      Patients are followed post-HSCT for the development of transplant related pulmonary\n      complications.  A repeat bronchoscopy with BAL is performed at the time pulmonary\n      complications develop or at day 60 post-HSCT if no complications develop.  Cytokine assays\n      are repeated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Diagnosis of an inborn error of metabolism eligible for allogeneic hematopoietic stem\n             cell transplantation on protocol UMN-MT-1995-01"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "10", 
        "firstreceived_date": "June 2, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00005900", 
            "org_study_id": "199/15111", 
            "secondary_id": [
                "UMN-MT-1999-18", 
                "UMN-MT-9818"
            ]
        }, 
        "keyword": [
            "Gaucher's disease", 
            "I cell disease", 
            "Niemann-Pick disease", 
            "Wolman disease", 
            "adrenoleukodystrophy", 
            "disease-related problem/condition", 
            "fucosidosis", 
            "genetic diseases and dysmorphic syndromes", 
            "globoid cell leukodystrophy", 
            "inborn errors of metabolism", 
            "mannosidosis", 
            "metachromatic leukodystrophy", 
            "mucopolysaccharidosis", 
            "mucopolysaccharidosis I", 
            "mucopolysaccharidosis VI", 
            "oncologic disorders", 
            "pulmonary complications", 
            "rare disease", 
            "sphingolipidoses"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55455"
                }, 
                "name": "Fairview University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Fairview University Medical Center", 
            "last_name": "K. Scott Baker", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005900"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fairview University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1999", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "October 2003"
    }, 
    "geocoordinates": {
        "Fairview University Medical Center": "44.98 -93.264"
    }
}